Skip to content
NASDAQ · PATENT OWNERS & LESSORS · SMALL CAP

Joint Corp. JYNT

13 fiscal years on record · USD · FY2025 reported · SEC filings only
$54.9M
▲ 5.2% YoY
$2.9M
$334,724
▼ 95.9% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The Joint Corp's mission is to improve quality of life through routine and affordable chiropractic care, and it is a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. It delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across its highly franchised network. Since acquiring the predecessor to the company in March 2010, it has grown its enterprise from eight to 960 clinics in operation as of December 31, 2025, with an additional 82 franchise licenses sold but not yet developed across its network, and 57 letters of intent for 57 future clinic licenses. As of December 31, 2025, its franchisees owned or managed 885 clinics, and the company owned or managed 75 clinics. It collects a royalty of 7.0% of gross sales from franchised clinics, remits a 3.0% royalty to regional developers on the gross sales of franchises opened within certain regional developer protected territories, and also collects a national marketing fee of 2.0% of gross sales of all franchised clinics. As of December 31, 2025, it had 960 franchised or company-owned or managed clinics in operation in 43 states.

Written from the business description in JOINT Corp's annual report to the U.S. Securities and Exchange Commission, filed 13 March 2026. Every sentence was checked against that document before publication.

Growth

USD 54.9M
Revenue, FY2025 · full 13-year series below
Revenue $M Net income $M
FY2025 · Revenue 54.9 · Net income 2.9
30M60M-10M-20M
20132016201920222025
Compound annual growth
+1.7%
−1.3%
+14.8%
−26.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −1.3% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

5 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating -1.7% · Net 5.3%
10%20%-20%-40%-60%
201320192025
ROE
FY2023 · ROE -34.0%
50%100%-50%-100%
201320192025
Three returns, three denominators.
Return on equityNot available: we don't have a clean profit figure for this period.

Return on equity has no reading this year — return on capital employed, just below, still does: -3%.

Cash & shareholders

USD 9.8M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 0.3
4M8M-5M-10M
201320192025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 9.8
4M8M
201320172019202120232025

USD 9.8M in buybacks — Not available: we don't have a clean profit figure for this period.

Total assetsUSD 61.0M
EquityUSD 15.1M
CashUSD 23.6M
Current ratio1.59×

Equity funds 25% of total assets.

The 13-year record

13 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
JYNT, 13-year financial record
Metric 2025202420232022202120202019201820172016201520142013
Revenue $B0.10.10.00.10.10.10.00.00.00.00.00.00.0
Operating income $B−0.0−0.00.0−0.00.00.00.00.0−0.0−0.0−0.0−0.00.0
EBITDA $B0.00.00.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
Income tax $B0.00.00.00.0−0.0−0.00.0−0.00.00.0−0.00.00.0
Net income $B0.0−0.0−0.0−0.00.00.00.00.0−0.0−0.0−0.0−0.00.0
Free cash flow $B0.00.00.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
EPS, diluted $0.19−0.38−0.65−0.380.510.900.230.01−0.26−1.20−0.88−0.560.02
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————
ROE %◌◌−34.02.029.498.1103.115.6−85.0−109.9−48.5——
Shares out B0.010.020.010.010.010.010.010.010.010.010.010.010.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 51 reconciliationsAUDITED

Reconciled in 13 of the 13 fiscal years we could check. 12 checks were skipped: the balance sheet is not tagged before 2013. Six checks were skipped: EPS is not tagged before 2013. Six checks were skipped: revenue is not tagged before 2013.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPatent Owners & Lessors
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2013

Share this section

Download image